A new survey shows cancer patients and recent survivors have had a positive experience using telehealth in the wake of the pandemic and are willing to use or adapt to using telehealth services in the future.
As Congress prepares to consider the Build Back Better Act, cancer patients, survivors and their caregivers are urging lawmakers to make sure certain key health provisions are included in any final legislation.
As lawmakers deliberate which health care priorities to include in the budget reconciliation package, ACS CAN is strongly urging Congress and the Administration to once and for all permanently close the Medicaid coverage gap and provide access to quality, affordable coverage to millions of Americans.
ACS CAN President Lisa Lacasse expresses concern over FDA's approval of four flavored tobacco products.
More than 20 patient and health care groups sent a letter to Congressional leadership and the Administration today making clear the need to preserve the nation’s first-ever paid family and medical leave program as part of forthcoming reconciliation legislation.
The Food and Drug Administration announced this afternoon it has issued marketing orders for the first e-cigarette products authorized by the agency.
Dr. Karen E. Knudsen, CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) issued the following statement in response to the announced retirement of the National Institutes of Health Director, Dr. Francis Collins.
WASHINGTON, D.C.—According to a study released today by the Centers for Disease Control and Prevention and the U.S.
Nearly 700 cancer advocates, including patients, survivors and their loved ones, from all 50 states and territories and nearly every congressional district will dial into calls and log onto virtual meetings this week to ask members of Congress to make the fight against cancer a national priority
ACS CAN is advocating for a pathway for Medicare coverage for innovative cancer early detection, once Multi-Cancer Early Detection Tests are FDA approved and clinical benefit is shown.